IS4152A - Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra - Google Patents

Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Info

Publication number
IS4152A
IS4152A IS4152A IS4152A IS4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A IS 4152 A IS4152 A IS 4152A
Authority
IS
Iceland
Prior art keywords
production
water
camptothecin derivatives
soluble camptothecin
soluble
Prior art date
Application number
IS4152A
Other languages
English (en)
Icelandic (is)
Inventor
Joseph Luzzio Michael
Mark Besterman Jeffrey
G. Evans Michael
Leslie Myers Peter
Original Assignee
Glaxo Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc. filed Critical Glaxo Inc.
Publication of IS4152A publication Critical patent/IS4152A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4152A 1993-04-29 1994-04-25 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra IS4152A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5458593A 1993-04-29 1993-04-29
US8104293A 1993-06-22 1993-06-22

Publications (1)

Publication Number Publication Date
IS4152A true IS4152A (is) 1994-10-30

Family

ID=26733234

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4152A IS4152A (is) 1993-04-29 1994-04-25 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Country Status (10)

Country Link
EP (1) EP0696285A1 (fr)
JP (1) JPH08509740A (fr)
AP (1) AP9400638A0 (fr)
AU (1) AU6777194A (fr)
CA (1) CA2161681A1 (fr)
IL (1) IL109470A0 (fr)
IS (1) IS4152A (fr)
MY (1) MY141374A (fr)
PE (1) PE52894A1 (fr)
WO (1) WO1994025466A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6504029B1 (en) * 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
TW464652B (en) 1996-10-30 2001-11-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165346T3 (es) * 1989-09-15 2002-03-16 Res Triangle Inst Analogos de 10,11-metilendioxi-20(rs)-camptotecina y 10,11-metilendioxi-20(s)-camptotecina.
EP0540099B1 (fr) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Dérivés de camptothécine solubles dans l'eau
EP0556585A3 (fr) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Dérivés de la camptothécine condensés, leur préparation et leur utilisation comme agents antitumoraux

Also Published As

Publication number Publication date
JPH08509740A (ja) 1996-10-15
EP0696285A1 (fr) 1996-02-14
WO1994025466A1 (fr) 1994-11-10
AP9400638A0 (en) 1995-10-28
IL109470A0 (en) 1994-07-31
PE52894A1 (es) 1995-01-06
CA2161681A1 (fr) 1994-11-10
AU6777194A (en) 1994-11-21
MY141374A (en) 2010-04-16

Similar Documents

Publication Publication Date Title
IS4092A (is) Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
IS3805A (is) Amínósýruafleiður og aðferð við framleiðslu þeirra
IS1708B (is) Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
PL315174A1 (en) Novel derivatives of gingolydes and method of obtaining them
IS4717A (is) Blöndur af skordýraeitri í örhylkjum og aðferð við framleiðslu þeirra
DK50889A (da) Cyclomaltodextringlucantransferase og fremgangsmaade til fremstilling heraf
IS3555A7 (is) Pyrrol-afleiður og aðferð til framleiðslu þeirra
PL305288A1 (en) Novel piperidine derivatives, method of obtaining them and pharmaceutical agent
IS3792A7 (is) Benzodiazepinones og aðferð til framleiðslu þess
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
AU4186989A (en) Hollow jewellery objects and method
IS3857A (is) Karboxýl-sýruafleiður og aðferð til framleiðslu þeirra
DK0774086T3 (da) Kædeled, forbindelsesstykke til kædeled og fremgangmåde til fremstilling deraf
IS3603A7 (is) Brennslukol og aðferð til framleiðslu þeirra
DK223089D0 (da) Lysdaemper og fremgangsmaade til fremstilling deraf
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
IS4152A (is) Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
IS4050A (is) Fóður og aðferð við framleiðslu þess
IS4779A (is) Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu
IS3725A7 (is) Amínósýruafleiður og aðferð til framleiðslu þeirra
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
IS4033A (is) Hliðstæð aðferð til framleiðslu á isobenzofuranylafleiðum og milliefni til notkunar með aðferðinni
IS1742B (is) Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)alkanafleiður og notkun þeirra við að vernda taugar